Edition:
United Kingdom

Vascular Biogenics Ltd (VBLT.OQ)

VBLT.OQ on NASDAQ Stock Exchange Global Market

1.65USD
21 Aug 2018
Change (% chg)

$0.05 (+3.12%)
Prev Close
$1.60
Open
$1.60
Day's High
$1.65
Day's Low
$1.60
Volume
6,466
Avg. Vol
18,349
52-wk High
$9.05
52-wk Low
$1.58

Chart for

About

Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of treatments for cancer. The Company's program is based on its Vascular Targeting System (VTS) platform technology, which utilizes genetically targeted therapy to destroy newly... (more)

Overall

Beta: --
Market Cap(Mil.): $157.27
Shares Outstanding(Mil.): 27.12
Dividend: --
Yield (%): --

Financials

  VBLT.OQ Industry Sector
P/E (TTM): -- 85.69 32.76
EPS (TTM): -0.66 -- --
ROI: -42.25 1.78 14.61
ROE: -42.33 3.28 16.33

BRIEF-VBL Therapeutics Awarded $2.5 Million Non Dilutive Grant By The Israel Innovation Authority

* VBL THERAPEUTICS AWARDED $2.5 MILLION NON-DILUTIVE GRANT BY THE ISRAEL INNOVATION AUTHORITY Source text for Eikon: Further company coverage:

09 Apr 2018

BRIEF-VBL Therapeutics Announces Top-Line Results From Pivotal Phase 3 Globe Study In Patients With Recurrent Glioblastoma

* VBL THERAPEUTICS ANNOUNCES TOP-LINE RESULTS FROM PIVOTAL PHASE 3 GLOBE STUDY IN PATIENTS WITH RECURRENT GLIOBLASTOMA

08 Mar 2018

Earnings vs. Estimates